SCTX SCRIBE THERAPEUTIC COM revenue, earnings and financials
For the quarter ended June 30, 2026, SCRIBE THERAPEUTIC COM reported revenue of $1.92M (down 60.8% from a year earlier), net income of −$6.48M and diluted EPS of −$2.62.
SCTX quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $1.92M (down 60.8% year over year), net income −$6.48M, EPS −$2.62
- Quarter ended Mar 31, 2026: revenue n/a, net income −$17.3M, EPS n/a
- Quarter ended Jun 30, 2025: revenue $4.90M, net income −$9.90M, EPS −$4.08
- Quarter ended Mar 31, 2025: revenue n/a, net income −$3.43M, EPS n/a
SCTX balance sheet
- Jun 30, 2026: cash $35.6M, total assets $57.9M, total liabilities $102M, shareholders' equity −$165M
- Dec 31, 2025: cash $12.8M, total assets $78.2M, total liabilities $101M, shareholders' equity −$143M